A study to compare the pharmacokinetics and safety between CKD-379 and D759, D745, D029, D150 combination
A randomized, open-label, single dose, crossover study to evaluate the pharmacokinetic profiles and safety of CKD-379 in healthy volunteers under fed conditions
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
32
2 tablet administration under fed condition
4 tablet co-administration under fed condition
Chonbuk National University Hospital
Jeonju, South Korea
AUCt
Maximum plasma concentration of the drug
Time frame: 0~48hours
Cmax
Area under the concentration-time curve from the time of dosing to the last measurable concentration
Time frame: 0~48hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.